RG
BIIB icon

Retirement Group’s Biogen BIIB Stock Holding History

Retirement Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$10.6K Sell
49
-10
-17% -$2.34K ﹤0.01% 463
2023
Q4 		$15.3K Hold
59
– – 0.01% 383
2023
Q3 		$15.2K Sell
59
-5
-8% -$1.34K 0.01% 355
2023
Q2 		$18.2K Hold
64
– – 0.01% 331
2023
Q1 		$18K Hold
64
– – 0.01% 312
2022
Q4 		$18K Buy
64
+60
+1,500% +$16.9K 0.01% 288
2022
Q3 		$1K Sell
4
-133
-97% -$28.2K ﹤0.01% 429
2022
Q2 		$28K Buy
137
+64
+88% +$13.1K 0.01% 265
2022
Q1 		$15K Buy
73
+9
+14% +$1.96K 0.01% 386
2021
Q4 		$15K Buy
64
+5
+8% +$1.29K 0.01% 372
2021
Q3 		$17K Hold
59
– – 0.01% 329
2021
Q2 		$20K Sell
59
-258
-81% -$78.2K 0.01% 327
2021
Q1 		$89K Hold
317
– – 0.04% 199
2020
Q4 		$77K Buy
317
+267
+534% +$68.9K 0.04% 209
2020
Q3 		$14K Buy
50
+5
+11% +$1.4K 0.01% 366
2020
Q2 		$12K Buy
+45
New +$13.5K 0.01% 365
2019
Q4 		$1K Buy
+5
New +$1.39K ﹤0.01% 575

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Retirement Group's BIIB Position: Q1 2024 in Review

Retirement Group reduced its Biogen (BIIB) stake by 17% in Q1 2024, selling an estimated $2.34K and leaving 49 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Retirement Group first reported a position in BIIB in Q4 2019 and has held it in 17 quarters since. The position peaked at $89K in Q1 2021. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Retirement Group held 49 shares of Biogen worth $10.6K as of Q1 2024.
  • Retirement Group sold 10 Biogen shares in Q1 2024, an estimated $2.34K.
  • Biogen made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #463 holding.
  • Retirement Group first reported a position in Biogen in Q4 2019 and has held it in 17 quarters since.
  • Retirement Group's Biogen position peaked at $89K in Q1 2021.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.